UK: Merck to acquire EyeBio for up to US$3bn

UK-based EyeBiotech (EyeBio), a privately held ophthalmology-focused biotechnology company, is to be acquired by New York-listed global biotech company, Merck (MSD).  Under the terms of the agreement, MSD, through a […]